Source: International Congress 2018 – Latest developments in cystic fibrosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Sergio (Bresso, Italy), S. Pollini (Firenze, Italy), S. Boncompagni (Siena, Italy), T. Di Maggio (Siena, Italy), S. Aliberti (Milano, Italy), F. Blasi (Milano, Italy), L. Pallecchi (Firenze, Italy), G. Rossolini1 (Firenze, Italy). Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms. 3407

Member's Comments

No comment yet.

Related content which might interest you: Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Synergistic activity of N-acetylcysteine and colistin against Stenotrophomonas maltophilia Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Inhaled colistin on Acinetobacter baumannii treatment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Source: Eur Respir J 2003; 21: 401-406 Year: 2003 Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Evolution of tetracycline resistant S. aureus in hypoxia Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Pseudomonas aerugenosa sensitivity changes to antibiotics under the influence of dissolved ozone Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Macrolide resistance in Pseudomonas aeruginosa: implications for practice Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017 Year: 2017